ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

Variation in the Synovial Fluid Metabolome According to Disease Activity in Rheumatoid Arthritis

Joong Kyong Ahn1, Jiwon Hwang2, Jaejoon Lee3, Eun-Mi Koh3 and Hoon-Suk Cha3, 1Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 2Department of Internal Medicine, National Police Hospital, Seoul, Korea, Republic of (South), 3Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity, metabolomics, rheumatoid arthritis (RA) and synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease characterized by persistent inflammation and joint damage with a heterogeneous course and different pathogenic mechanisms. Metabolomics, defined as the comprehensive analysis of the small-molecule metabolites in a biological system, is a rapidly developing biomedical research area. This study was to investigate metabolic perturbation in the synovial fluid (SF) of RA patients according to the degree of disease activity using gas chromatography/time-of-flight-mass spectrometry (GC/TOF-MS) to gain more insight into the pathologic metabolic alterations in RA.

Methods: We included 47 patients with diagnosed active RA (15 male, 32 female). Disease activity was assessed using DAS28-ESR. SF metabolomic profiling was performed was performed using GC/TOF MS, in conjunction with multivariate statistical analyses and pathway analyses such as metabolite set enrichment analysis (MSEA).

Results: A total of 125 metabolites were identified from SF of RA, which were classified into various chemical classes, such as amino acids (21% of identified metabolites), organic acids (21%), sugar and sugar alcohols (18%), fatty acids (14%), amines (9%), and phosphates (5%).

We indicated statistical significant correlation between DAS28-ESR value and the intensities of 12 metabolites (β-alanine, asparagine, citrate, cyano-L-alanine, indol-3-lactate, leucine, nicotinamide, citrulline, methionine, oxoproline, salicylaldehyde, and glycocyamine). The intensities of glycocyamine and indol-3-lactate positively correlated with DAS28-ESR value (rho = 0.311, p = 0.017; rho = 0.345, p = 0.033). On the other hand, β-alanine, asparagine, citrate, cyano-L-alanine, leucine, nicotinamide, citrulline, methionine, oxoproline, and salicylaldehyde negatively correlated with DAS28-ESR.

To investigate whether metabolism is affected by disease activity in RA, we have performed MSEA and metabolic pathway analysis by using MetaboAnalyst. We found that the higher the disease activity, the more amino acid metabolic processes were affected. In MSEA, we found six unique pathways, namely, fructose and mannose degradation, phenylalanine and tyrosine metabolism, citric acid cycle, galactose metabolism, tryptophan metabolism and pyrimidine metabolism that were significantly associated with disease activity in RA.

Conclusion: Synovial metabolite perturbations, especially perturbation in amino acid metabolism, are suggested to be correlated with disease activity of RA. SF metabolomic approaches based on GC/TOF-MS can provide important information relating to monitor disease activity in RA and be important approach to understanding the altered metabolism and pathophysiology of RA.


Disclosure: J. K. Ahn, None; J. Hwang, None; J. Lee, None; E. M. Koh, None; H. S. Cha, None.

To cite this abstract in AMA style:

Ahn JK, Hwang J, Lee J, Koh EM, Cha HS. Variation in the Synovial Fluid Metabolome According to Disease Activity in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/variation-in-the-synovial-fluid-metabolome-according-to-disease-activity-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variation-in-the-synovial-fluid-metabolome-according-to-disease-activity-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology